OpenIcon research & analysis

Information Technology

Stocks Covered
Finance &

Foreseeing value & Offering insight

Seeking Alpha articles by William P. Meyers

Recent and Popular:

Questioning Agios Pharmaceuticals' Future Revenue December 7, 2018

Biogen Outlook For The 2020s November 30, 2018

Celgene's Positives Greatly Outweigh Negatives [November 20, 2018]

Microchip is a Buy on Pullback [August 20, 2018]

Alexion: Priced Right For Long-Term Investors [August 16, 2018 at Seeking Alpha]

Regeneron: A Buy On Dupixent And Pipeline [August 15, 2018 at Seeking Alpha]

Inovio: Time To Think About 2020 [July 11, 2018]

Star Bulk Undervalued On Rates, Oaktree Stock Sale [July 2, 2018]

Amgen Should Rebound [June 20, 2018]

Five Reasons Celgene Will Recover [Seeking Alpha, June 1, 2018]

Regeneron Unknown: Eylea Future Competition Effects [May 17, 2018]

Xilinx's ACAP Could Be A Computing Game-Changer [Seeking Alpha, April 27, 2018]

Biogen's Ionis Deal is Brilliant [April 25, 2018 at Seeking Alpha]

Agenus Mystery Therapy Indicates Possible Upside [March 19, 2018]

Endocyte Has a Strong Phase 3 Ready Asset
[January 31, 2018 at Seeking Alpha]

Buy Agios [January 10, 2018 at Seeking Alpha]

William Meyers changes 2018 stocks covered

Gilead Sciences Going Down When It Should Go Up [Seeking Alpha, 12/8/2017]

Celgene is Oversold [Seeking Alpha, 11/30/2017]

Immune Checkpoint Inhibitors

Biotechnology stocks covered

Biotech Research Help page

The Accounting System: The New Money Cloud

Links to Quarterly Results Notes

Dissecting the Bull blog

Finance and Economics Commentary


(experimental): Random Stock Picker

Machine Understanding (AI)